Cargando…
Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial
In this multicentre double-blind randomized clinical trial, we investigated the effects of oral cholecalciferol supplementation on serum hepcidin and parameters related to anaemia and CKD-MBD among haemodialysis patients. Participants were assigned in a 2:2:1:1 ratio to either (1) thrice-weekly 3,00...
Autores principales: | Obi, Yoshitsugu, Yamaguchi, Satoshi, Hamano, Takayuki, Sakaguchi, Yusuke, Shimomura, Akihiro, Namba-Hamano, Tomoko, Mikami, Satoshi, Nishi, Osamu, Tanaka, Motoko, Kamoto, Akihito, Obi, Yasue, Tomosugi, Naohisa, Tsubakihara, Yoshiharu, Isaka, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512011/ https://www.ncbi.nlm.nih.gov/pubmed/32968158 http://dx.doi.org/10.1038/s41598-020-72385-w |
Ejemplares similares
-
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study
por: Doi, Yohei, et al.
Publicado: (2021) -
Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact Matching
por: Obi, Yoshitsugu, et al.
Publicado: (2017) -
Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline
por: Hamano, Takayuki, et al.
Publicado: (2013) -
Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial
por: Tsujita, Makoto, et al.
Publicado: (2021) -
Prevalence and Prognostic Implications of Vitamin D Deficiency in Chronic Kidney Disease
por: Obi, Yoshitsugu, et al.
Publicado: (2015)